Featured news, clinical trials, MSU updates and more.
Orphazyme announces topline results of Phase 2/3 trial of arimoclomol for Inclusion Body Myositis (IBM)Myositis Support, , Featured, Inclusion Body Myositis (IBM), News
Learn more about the announcement from Orphazyme, communicating the topline results from the Phase 2/3 trial of arimoclomol for...
Choose your language
- Explore Myositis
- Financial Assistance Program
- #ItsMyTurn: Becoming a Plasma Donor Hero
- Myositis Clinical Trials
- Myositis Empower Walk
- Myositis Webinars
- The Grieving Project
- Upcoming Events
June 19 @ 3:00 pm - 4:30 pm EDT
June 25 @ 5:00 pm - 6:30 pm EDT
June 26 @ 3:00 pm - 4:30 pm EDT